Kochi Corporation in Kerala faces huge biomedical waste backlog as incinerator capacity is reduced

Kochi Corporation in Kerala faces huge biomedical waste backlog as incinerator capacity is reduced

**Kochi Grapples with Biomedical Waste Crisis Amidst Incinerator Malfunctions**

Kochi, Kerala – The Kochi Corporation is currently confronting a significant challenge in managing its biomedical waste, as a critical treatment facility experiences a substantial reduction in its operational capacity. This situation has led to a growing backlog of hazardous medical waste, raising concerns about public health and environmental safety within the region.

The Common Bio-Medical Waste Treatment Facility, operated by Kerala Enviro Infrastructure Limited (KEIL), is central to the disposal of infectious materials generated by healthcare institutions across Kochi. However, a recent series of operational setbacks has severely hampered its ability to process the volume of waste it typically handles. For a period of fifteen days last month, one of the facility’s two incinerators was rendered inoperable, creating an immediate bottleneck.

While the affected incinerator has since been brought back online, the facility’s operational capacity has not fully recovered. KEIL has implemented a restricted intake policy, limiting the daily processing of biomedical waste to three tonnes. This represents a considerable decrease from the facility’s usual capacity of five tonnes per day. The decision to reduce intake has been attributed to a strategic prioritization of hospital waste, suggesting that other categories of biomedical waste may be experiencing further delays in treatment.

Further compounding the issue, a snag was reportedly encountered during the trial run of the second incinerator located at the Brahmapuram facility. While details surrounding the nature and duration of this malfunction remain scarce, it indicates a broader systemic issue affecting the infrastructure designed for safe biomedical waste disposal in the area. The cumulative effect of these disruptions is a mounting backlog of untreated biomedical waste, posing a potential risk of contamination and disease transmission if not addressed promptly.

The implications of this waste management crisis are far-reaching. Biomedical waste, by its very nature, contains pathogens and hazardous substances that require specialized treatment to prevent the spread of infections. A prolonged backlog could lead to overflowing storage facilities at healthcare centers, increasing the risk of accidental exposure for medical staff and the general public. Furthermore, improper storage or disposal of such waste can contaminate soil and water sources, leading to long-term environmental degradation.

Local authorities and KEIL are reportedly engaged in efforts to mitigate the crisis. However, the specifics of their action plan and the timeline for restoring full operational capacity are yet to be fully disclosed. The situation underscores the critical importance of robust and resilient waste management infrastructure, particularly for hazardous materials generated by the healthcare sector.

The Kochi Corporation’s current predicament serves as a stark reminder of the vulnerabilities inherent in waste management systems. The reliance on a limited number of treatment facilities, coupled with the potential for mechanical failures, can quickly escalate into a public health emergency. As the corporation navigates this challenging period, transparency regarding the ongoing efforts and a clear roadmap for resolving the backlog will be crucial in reassuring the public and safeguarding the health of the community. The immediate priority must be the swift and safe processing of accumulated biomedical waste to avert any further health and environmental risks.

This article was created based on information from various sources and rewritten for clarity and originality.